While the two approaches — active databases and event streaming databases — may appear to be similar, they are used in different ways. Both build on the same three building blocks: queries, tables, and event streams. Active databases are better at queries over tables, but they can't query event streams. Event streaming databases can query both event streams and tables, but the table-based queries are less advanced than their active database counterparts. What this means in practice is that active databases suit simple applications or individual microservices that can benefit from an event-based interface to the data held. By contrast, event streaming databases typically use Apache Kafka to move data around, making them better suited to microservices (plural) or data pipelines. They serve as systems in which event data physically moves from one place to another, or creates chains of business logic tied together by these data flows — quite literally turning the database inside out. These are also the exact types of applications we see taking human taxi operators, credit officers, checkout clerks, etc., off the critical path.
8B USD, and had highs of over $2B USD. Which would be $2. 3B AUD. They are currently conducting a Phase 2B Clinical Trial using psilocybin therapy for depression across 21 sites in 10 different countries. Compass has over 10 bagged since IPOing in September 2020. In relation, IHL has planned Australia's largest ever clinical trial of psilocybin therapy for anxiety in collaboration with Monash University. This would be a Phase 2 trial and whilst a ways off from recruiting and commencing, the similarities to Compass are obvious. II: MindMed (MMEDF:OTCQB) MindMed boasts a valuation of $900M USD, and had highs of $1. 27B USD. This would be $1. 16B AUD. The company is engaging in LSD assisted therapy for anxiety, and is currently in Phase 2A of clinical development. Furthermore, they have successfully completed a Pre-IND meeting with the FDA for this project. IHL is engaging in a similar task with its psilocybin assisted therapy for anxiety, and will certainly seek out the FDA for a Pre-IND meeting just like MindMed when the time is right.